- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge extends European CAD sales
Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy.
Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy. The new markets represent the extension of an existing distribution agreement between the two companies addressing CADstream sales in the European Union. Merge has been ramping up educational efforts for EU radiologist, holding workshops on breast MRI in Germany and the U.K., and scheduling a course this month in France in November. CADstream joined the Merge portfolio with the acquisition earlier this year of its developer, Confirma, which is now the Merge CAD business unit. CADstream automates the analysis and interventional guidance of MRI studies. The company claims 1200 installed sites worldwide.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
